ApcMIN modulation of vitamin D secosteroid growth control

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1434-1441

  Xu, Haibo ^c   Posner, Gary H ^b   Stevenson, Michael ^a   Campbell, Frederick C ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALPHA HYDROXYMETHYL 16 ENE 24,24 DIFLUORO 25 HYDROXY 26,27 BISHOMOVITAMIN D3; APC PROTEIN; BETA CATENIN; CALCITRIOL; CALCIUM; HERMES ANTIGEN; MYC PROTEIN; OSTEOPONTIN; QW 1624F2 2; SECOSTEROID; TRANSCRIPTION FACTOR 7; UNCLASSIFIED DRUG; UVOMORULIN; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CADHERINS; COLON; COLORECTAL NEOPLASMS; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; INTESTINAL POLYPS; MICE; MICE, INBRED C57BL; OSTEOPONTIN; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; RISK FACTORS; RNA, MESSENGER; VITAMIN D; WEIGHT GAIN;

EID: 77955387570     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq098     Document Type: Article

References (72)

1. Bouillon,R. et al. (1995) Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 16, 200-257.
2. Peters,U. et al. (2004) Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev., 13, 546-552.
3. Wu,K. et al. (2007) A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J. Natl Cancer Inst., 99, 1120-1129.
4. Jenab,M. et al. (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ, 340, b5500.
5. Freedman,D.M. et al. (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl Cancer Inst., 99, 1594-602.
6. Chen,W. et al. (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br. J. Cancer, 97, 123-128.
7. Ahn,J. et al. (2008) Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J. Natl Cancer Inst., 100, 796-804.
8. Wood,R.J. et al. (2004) DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. Physiol. Genomics, 17, 122-129.
9. Chang,P.L. et al. (1993) 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate-induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells. Cancer Res., 53 (10 suppl.), 2217-2220.
10. Palmer,H.G. et al. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell Biol., 154, 369-387.
11. Denhardt,D.T. et al. (1993) Osteopontin: a protein with diverse functions. FASEB J., 7, 1475-1482.
12. Kim,S. et al. (2005) 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res., 20, 305-317.
13. Ordonez-Moran,P. et al. (2008) RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J. Cell Biol., 183, 697-710.
14. Denhardt,D.T. et al. (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest., 107, 1055-1061.
15. Bellahcene,A. et al. (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat. Rev. Cancer, 8, 212-226.
16. Lin,Y.H. et al. (2001) The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J. Biol. Chem., 276, 46024-46030.
17. Teramoto,H. et al. (2005) Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene, 24, 489-501.
18. Harada,N. et al. (2001) Introduction of antisense CD44S CDNA downregulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int. J. Cancer, 91, 67-75.
19. Chang,P.L. et al. (1997) Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways. Clin. Exp. Metastasis, 15, 580-592.
20. Agrawal,D. et al. (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl Cancer Inst., 94, 513-521.
21. Gottardi,C.J. et al. (2001) E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol., 153, 1049-1060.
22. Stockinger,A. et al. (2001) E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J. Cell Biol., 154, 1185-1196.
23. Hirohashi,S. (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol., 153, 333-339.
24. Nelson,W.J. et al. (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 303, 1483-1487.
25. Herzig,M. et al. (2007) Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene, 26, 2290-2298.
26. Onder,T.T. et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res., 68, 3645-3654.
27. Vesuna,F. et al. (2009) Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia, 11, 1318-1328.
28. Norman,A.W. et al. (2001) Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J. Steroid Biochem. Mol. Biol., 76, 49-59.
29. Liu,Y.Y. et al. (2000) Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor. Mol. Endocrinol., 14, 1776-1787.
30. Posner,G.H. et al. (1997) Antiproliferative hybrid analogs of the hormone 1alpha,25-dihydroxyvitamin D(3): design, synthesis, and preliminary biological evaluation. J. Org. Chem., 62, 3299-3314.
31. Posner et al. (2004) Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry. Steroids, 69, 757-62.
32. Xu,H. et al. (2009) Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals. Mol. Carcinog., 48, 758-72.
33. Posner,G.H. et al. (2002) 2,2-Disubstituted analogues of the natural hormone 1 alpha,25-dihydroxyvitamin D(3): chemistry and biology. Bioorg. Med. Chem., 10, 2353-2365.
34. Tangpricha,V. et al. (2005) Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J. Nutr., 135, 2350-2354.
35. Pakkala,S. et al. (1995) Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk. Res., 19, 65-72.
36. Morgan,B.R. et al. (1993) Calcium determination in serum with stable alkaline Arsenazo III and triglyceride clearing. Clin. Chem., 39, 1608-1612.
37. Bashir,O. et al. (2004) Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse. Carcinogenesis, 25, 1507-1515.
38. Sattar,A. et al. (1999) Metabolic proficiency and benzo[a]pyrene DNA adduct formation in APCMin mouse adenomas and uninvolved mucosa. Carcinogenesis, 20, 1097-1101.
39. Donnelly,E.T. et al. (2005) Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. Br. J. Cancer, 92, 2160-2165.
40. Harbottle,A. et al. (2001) Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance. Int. J. Cancer, 92, 777-783.
41. Tuck,A.B. et al. (1999) Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene, 18, 4237-4246.
42. Chen,L.C. et al. (2004) Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res., 64, 3694-3700.
43. Kinzler,K.W. et al. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
44. Barker,N. et al. (2000) The Yin-Yang of TCF/beta-catenin signaling. Adv. Cancer Res., 77, 1-24.
45. Howe,L.R. et al. (2003) Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res., 63, 1906-1913.
46. Zhu,P. et al. (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell, 5, 455-463.
47. Vietor,I. et al. (2005) TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent. J. Biol. Chem., 280, 39795-39801.
48. Bordonaro,M. et al. (2007) The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp. Cell Res., 313, 1652-1666.
49. Peinado,H. et al. (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol., 48, 365-375.
50. Godman,C.A. et al. (2008) HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol. Ther., 7, 1570-1580.
51. Yang,K. et al. (2008) Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res., 68, 7803-7810.
52. Fodde,R. et al. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer, 1, 55-67.
53. Nagase,H. et al. (1993) Mutations of the APC (adenomatous polyposis coli) gene. Hum. Mutat., 2, 425-434.
54. Joslyn,G. et al. (1993) Dimer formation by an N-terminal coiled coil in the APC protein. Proc. Natl Acad. Sci. USA, 90, 11109-11113.
55. Mahmoud,N.N. et al. (1997) Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res., 57, 5045-5050.
56. Su,L.K. et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
57. van der Luijt,R.B. et al. (1996) Germline mutations in the 3( part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum. Genet., 98, 727-734.
58. Huerta,S. et al. (2002) 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res., 62, 741-746.
59. Campbell,F.C. et al. (2010) The Yin and Yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissuespecific growth control. Biochem. Pharmacol., 79, 1-9.
60. Jenis,L.G. et al. (1993) 1 alpha,25-dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression. J. Cell. Biochem., 53, 234-239.
61. Eelen,G. et al. (2008) Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. Chem. Biol., 15, 1029-1034.
62. Vieth,R. et al. (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr., 73, 288-294.
63. Fearon,E.R. et al. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
64. Phelps,R.A. et al. (2009) A two-step model for colon adenoma initiation and progression caused by APC loss. Cell, 137, 623-634.
65. Denhardt,D.T. et al. (2003) Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clin. Exp. Metastasis, 20, 77-84.
66. Hofmann,M. et al. (1993) A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res., 53, 1516-1521.
67. Peinado,H. et al. (2003) Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem., 278, 21113-21123.
68. Taber,L.M. et al. (2009) Mechanisms of nuclear vitamin D receptor resistance in Harvey-ras-transfected cells. J. Nutr. Biochem., 20, 629-637.
69. Larriba,M.J. et al. (2007) The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr. Relat. Cancer, 14, 141-151.
70. Levy,D.B. et al. (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res., 54, 5953-5958.
71. Stolzenberg-Solomon,R.Z. et al. (2006) A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res., 66, 10213-10219.
72. Sancho,E. et al. (2004) Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol., 20, 695-723.